Postmenopausal women at high risk for breast cancer have a new option for chemoprevention, which appears to be safer and more effective than SERMs. br / iMedscape Medical News/i
Adoptive cellular gene immunotherapy is a developing technology that may offer new hope to patients with cancer. The current case study and discussion describe the application of this treatment to a patient with glioblastoma mulitforme. Nature Clinical Practice Oncology
The tyrosine kinase inhibitor pazopanib has received approval for the treatment of advanced soft tissue sarcoma in previously treated patients. FDA Approvals
